Bank of Montreal
IBRX icon

Bank of Montreal’s ImmunityBio IBRX Stock Holding History

Bank of Montreal’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$130K Buy
16,914
+6,893
+69% +$47.2K ﹤0.01% 3064
2025
Q4 		$19.8K Sell
10,021
-2,501
-20% -$5.67K ﹤0.01% 3351
2025
Q3 		$30.8K Hold
12,522
– – ﹤0.01% 3211
2025
Q2 		$33.1K Sell
12,522
-1,702
-12% -$4.58K ﹤0.01% 3217
2025
Q1 		$42.8K Buy
14,224
+1,502
+12% +$4.55K ﹤0.01% 3096
2024
Q4 		$32.6K Sell
12,722
-249,200
-95% -$1.04M ﹤0.01% 3190
2024
Q3 		$1.03M Buy
261,922
+250,900
+2,276% +$1.16M ﹤0.01% 2023
2024
Q2 		$80.2K Sell
11,022
-14,400
-57% -$94.9K ﹤0.01% 3304
2024
Q1 		$140K Sell
25,422
-36,999
-59% -$168K ﹤0.01% 3195
2023
Q4 		$325K Buy
62,421
+14,061
+29% +$44.1K ﹤0.01% 2809
2023
Q3 		$87K Buy
+48,360
New +$97.1K ﹤0.01% 3315
2023
Q2 		– Sell
-101,469
Closed -$196K – 4123
2023
Q1 		$196K Buy
101,469
+3,508
+4% +$10.9K ﹤0.01% 3023
2022
Q4 		$503K Buy
97,961
+201
+0.2% +$1.1K ﹤0.01% 2606
2022
Q3 		$517 Buy
+97,760
New +$445K ﹤0.01% 2562
2021
Q2 		– Sell
-32,648
Closed -$610K – 4234
2021
Q1 		$610K Buy
32,648
+24,494
+300% +$635K ﹤0.01% 2522
2020
Q4 		$117K Buy
8,154
+3,392
+71% +$32.6K ﹤0.01% 3499
2020
Q3 		$36K Buy
4,762
+2,473
+108% +$24.7K ﹤0.01% 3566
2020
Q2 		$32K Buy
+2,289
New +$12.9K ﹤0.01% 3633
2020
Q1 		– Sell
-30,300
Closed -$115K – 4352
2019
Q4 		$115K Hold
30,300
– – ﹤0.01% 3426
2019
Q3 		$37K Buy
+30,300
New +$37.6K ﹤0.01% 3770
2019
Q1 		– Sell
-379
Closed – – 4510
2018
Q4 		$0 Sell
379
-4
-1% -$9 ﹤0.01% 4742
2018
Q3 		$2K Sell
383
-2
-0.5% -$6 ﹤0.01% 4358
2018
Q2 		$2K Buy
+385
New +$1.43K ﹤0.01% 4358
2017
Q4 		– Sell
-3,500
Closed -$19K – 4232
2017
Q3 		$19K Sell
3,500
-26,291
-88% -$162K ﹤0.01% 3536
2017
Q2 		$226K Buy
+29,791
New +$129K ﹤0.01% 2607

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Bank of Montreal's IBRX Position: Q1 2026 in Review

Bank of Montreal increased its ImmunityBio (IBRX) stake by 69% in Q1 2026, buying an estimated $47.2K and bringing the position to 16,914 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #3064.

Bank of Montreal first reported a position in IBRX in Q2 2017 and has held it in 25 quarters since. The position peaked at $1.03M in Q3 2024. 386 funds tracked by Wall St. Rank hold IBRX as of Q1 2026.

  • Bank of Montreal held 16,914 shares of ImmunityBio worth $130K as of Q1 2026.
  • Bank of Montreal bought 6,893 ImmunityBio shares in Q1 2026, an estimated $47.2K.
  • ImmunityBio made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #3064 holding.
  • Bank of Montreal first reported a position in ImmunityBio in Q2 2017 and has held it in 25 quarters since.
  • Bank of Montreal's ImmunityBio position peaked at $1.03M in Q3 2024.
  • 386 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.